Syndax Pharmaceuticals Inc — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Meury William | — | Award / Grant | 16,000 | — | — | 16,000 | Feb 3, 2021 |
| Legault Pierre | — | Award / Grant | 16,000 | — | — | 16,000 | Feb 3, 2021 |
| Katkin Keith | — | Award / Grant | 16,000 | — | — | 16,000 | Feb 3, 2021 |
| Jarrett Jennifer | — | Award / Grant | 16,000 | — | — | 16,000 | Feb 3, 2021 |
| Egros Fabrice | — | Award / Grant | 16,000 | — | — | 16,000 | Feb 3, 2021 |
| Metzger Michael A | President and COO | Option Exercise | 15,000 | $7.20 | $108,000 | 32,659 | Feb 1, 2021 |
| Morrison Briggs | Chief Executive Officer | Other | 1,771 | $12.00 | $21,252 | 48,336 | Jan 31, 2021 |
| Metzger Michael A | President and COO | Sale | 15,000 | $22.97 | $344,550 | 17,659 | Dec 1, 2020 |
| Ordentlich Peter | Chief Scientific Officer | Sale | 7,954 | $23.58 | $187,555 | 16,334 | Nov 23, 2020 |
| Morrison Briggs | Chief Executive Officer | Sale | 62,938 | $20.04 | $1,261,278 | 46,565 | Nov 9, 2020 |
| Metzger Michael A | President and COO | Sale | 100,000 | $20.31 | $2,031,000 | 17,659 | Nov 4, 2020 |
| Meyers Michael L. | SVP, Chief Medical Officer | Other | 1,771 | $12.00 | $21,252 | 15,166 | Jul 31, 2020 |
| Meyers Michael L. | SVP, Chief Medical Officer | Award / Grant | 3,500 | — | — | 10,730 | Jul 6, 2020 |
| Metzger Michael A | President and COO | Award / Grant | 15,000 | — | — | 17,659 | Feb 12, 2020 |
| Morrison Briggs | Chief Executive Officer | Purchase | 12,500 | $8.00 | $100,000 | 43,900 | Feb 4, 2020 |
| Shea Richard P | Chief Financial Officer | Other | 1,401 | $4.89 | $6,851 | 5,616 | Jan 31, 2020 |
| Morrison Briggs | Chief Executive Officer | Purchase | 11,000 | $5.40 | $59,400 | 31,400 | Oct 10, 2019 |
| Morrison Briggs | Chief Executive Officer | Purchase | 7,200 | $7.29 | $52,488 | 20,400 | May 9, 2019 |
| Meyers Michael L. | SVP, Chief Medical Officer | Purchase | 8 | $4.87 | $39 | 7,230 | Mar 21, 2019 |
| Meyers Michael L. | SVP, Chief Medical Officer | Purchase | 104 | $4.87 | $506 | 7,222 | Mar 21, 2019 |
| Shea Richard P | Chief Financial Officer | Other | 2,521 | $4.76 | $12,000 | 4,215 | Jan 31, 2019 |
| Meyers Michael L. | SVP, Chief Medical Officer | Other | 3,720 | $4.76 | $17,707 | 6,118 | Jan 31, 2019 |
| Metzger Michael A | President and COO | Other | 2,659 | $4.76 | $12,657 | 2,659 | Jan 31, 2019 |
| Meyers Michael L. | SVP, Chief Medical Officer | Purchase | 200 | $4.79 | $958 | 2,398 | Oct 30, 2018 |
| BIOTECHNOLOGY VALUE FUND L P | — | Other | 705,863 | — | — | 318,021 | Jun 18, 2018 |
| Ordentlich Peter | Chief Scientific Officer | Sale | 7,500 | $15.00 | $112,500 | — | Apr 3, 2018 |
| Ordentlich Peter | Chief Scientific Officer | Option Exercise | 732 | $3.08 | $2,255 | 5,000 | May 17, 2017 |
| ROYSTON IVOR | — | Disposition | 125,000 | $13.75 | $1,718,750 | 625,545 | Mar 20, 2017 |
| Halak Brian K | — | C | 761,062 | — | — | 761,062 | Mar 8, 2016 |
| DOVEY BRIAN H | — | C | 5,641 | — | — | 5,641 | Mar 8, 2016 |
| GADICKE ANSBERT | — | C | 718,396 | — | — | 1,856,606 | Mar 8, 2016 |
| ROYSTON IVOR | — | Purchase | 150,000 | $12.00 | $1,800,000 | 750,545 | Mar 8, 2016 |
| EVNIN LUKE | — | C | 718,396 | — | — | 1,856,606 | Mar 8, 2016 |
| BLAIR JAMES C | — | C | 13,925 | — | — | 13,925 | Mar 8, 2016 |
| DOVEY BRIAN H | — | C | 1,743,854 | — | — | 1,743,854 | Mar 8, 2016 |